Abiopharma

New Form F-6 POS - SOLAI Ltd <b>Filed:</b> 2026-07-06 <b>AccNo:</b> 0000950127-26-000056 <b>Size:</b> 196 KB

SLAI attributes changed: Attr: Sec_name SOLAI Limited American Depositary Shares (each representing one hundred (100) Class A Ordinary Shares) -> SOLAI Limited American Depositary Shares (each representing seven hundred (700) Class A Ordinary Shares);

SOLAI Announces Plan to Implement ADS Ratio Change

SOLAI Completes Acquisition of 51% Stake in NEURALAND

SOLAI Announces Agreement to Acquire 51% Stake in NEURALAND

New Form 3 - SOLAI Ltd <b>Filed:</b> 2026-05-29 <b>AccNo:</b> 0001104659-26-067850 <b>Size:</b> 4 KB

SOLAI Limited Announces Unaudited Financial Results for the Three Months Ended March 31, 2026

SOLAI Limited Receives Additional Notice Regarding NYSE Continued Listing Standards

SOLAI Limited to Report First Quarter 2026 Financial Results on May 26, 2026

SOLAI Begins Official Sale of Solode Neo, Enabling Always-On AI Agents Across Claude Code, OpenAI Codex, and Hermes